| Website | carbylan.com |
| Category | BioTech |
| Phone | 650-855-6777 |
| info@carbylan.com | |
| Employees | |
| Founded | 2005 |
| Description | Biopolymer Production |
| TOTAL | $20M |
| FUNDING TOTAL | $20M |
| Series B, 11/07 Vivo Ventures Alta Partners InterWest Partners | $20M |
Carbylan was founded in 2005 to develop and market medical devices and device/drug combination products based on chemically engineered polymers of hyaluronic acid, a well known polysaccharide widely present in the human body.
Its initial market focus is therapeutic medical devices for rhinosinusitis and osteoarthritis. Carbylan’s proprietary technology enables delivery of biomaterial-based medical devices as injectable liquids that self-polymerize inside the body to form therapeutic implants that covalently bind to tissues at the target delivery site.
